APA (7th ed.) Citation

Eron, J. J., Yetzer, E. S., Ruane, P. J., Becker, S., Sawyerr, G. A., Fisher, R. L., . . . Shaefer, M. S. (2000). Efficacy, safety, and adherence with a twice-daily combination lamivudine/zidovudine tablet formulation, plus a protease inhibitor, in HIV infection. AIDS (London), 14(6), 671-681. https://doi.org/10.1097/00002030-200004140-00006

Chicago Style (17th ed.) Citation

Eron, Joseph J., Ellen S. Yetzer, Peter J. Ruane, Stephen Becker, Gosford A. Sawyerr, Robin L. Fisher, Jerry M. Tolson, and Mark S. Shaefer. "Efficacy, Safety, and Adherence with a Twice-daily Combination Lamivudine/zidovudine Tablet Formulation, Plus a Protease Inhibitor, in HIV Infection." AIDS (London) 14, no. 6 (2000): 671-681. https://doi.org/10.1097/00002030-200004140-00006.

MLA (9th ed.) Citation

Eron, Joseph J., et al. "Efficacy, Safety, and Adherence with a Twice-daily Combination Lamivudine/zidovudine Tablet Formulation, Plus a Protease Inhibitor, in HIV Infection." AIDS (London), vol. 14, no. 6, 2000, pp. 671-681, https://doi.org/10.1097/00002030-200004140-00006.